These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
607 related items for PubMed ID: 10975993
1. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice. de Villiers WJ, Varilek GW, de Beer FC, Guo JT, Kindy MS. Cytokine; 2000 Sep; 12(9):1337-47. PubMed ID: 10975993 [Abstract] [Full Text] [Related]
2. Down-regulation of the major circulating precursors of proteins deposited in secondary amyloidosis by a recombinant mouse interleukin-1 receptor antagonist. Grehan S, Herbert J, Whitehead AS. Eur J Immunol; 1997 Oct; 27(10):2593-9. PubMed ID: 9368615 [Abstract] [Full Text] [Related]
3. Involvement of CD14 and toll-like receptor 4 in the acute phase response of serum amyloid A proteins and serum amyloid P component in the liver after burn injury. Cho K, Pham TN, Crivello SD, Jeong J, Green TL, Greenhalgh DG. Shock; 2004 Feb; 21(2):144-50. PubMed ID: 14752288 [Abstract] [Full Text] [Related]
5. Association of apolipoprotein E with murine amyloid A protein amyloid. Kindy MS, King AR, Perry G, de Beer MC, de Beer FC. Lab Invest; 1995 Oct; 73(4):469-75. PubMed ID: 7474917 [Abstract] [Full Text] [Related]
9. Antisense oligonucleotide suppression of serum amyloid A reduces amyloid deposition in mice with AA amyloidosis. Kluve-Beckerman B, Hardwick J, Du L, Benson MD, Monia BP, Watt A, Crooke RM, Mullick A. Amyloid; 2011 Sep; 18(3):136-46. PubMed ID: 21830877 [Abstract] [Full Text] [Related]
11. Acute phase induction of mouse serum amyloid P component. Correlation with other parameters of inflammation. Zahedi K, Whitehead AS. J Immunol; 1989 Nov 01; 143(9):2880-6. PubMed ID: 2809211 [Abstract] [Full Text] [Related]
12. Anaemia of chronic disease in AA amyloidosis is associated with allele 2 of the interleukin-1beta-511 promoter gene and raised levels of interleukin-1beta and interleukin-18. Maury CP, Liljeström M, Laiho K, Tiitinen S, Kaarela K, Hurme M. J Intern Med; 2004 Aug 01; 256(2):145-52. PubMed ID: 15257727 [Abstract] [Full Text] [Related]
13. Fenofibrate inhibits reactive amyloidosis in mice. Murai T, Yamada T, Miida T, Arai K, Endo N, Hanyu T. Arthritis Rheum; 2002 Jun 01; 46(6):1683-8. PubMed ID: 12115201 [Abstract] [Full Text] [Related]
14. Ubiquitin: its potential significance in murine AA amyloidogenesis. Chronopoulos S, Lembo P, Alizadeh-Khiavi K, Ali-Khan Z. J Pathol; 1992 Jun 01; 167(2):249-59. PubMed ID: 1321903 [Abstract] [Full Text] [Related]
15. Expression of a biologically active recombinant mouse IL-1 receptor antagonist and its use in vivo to modulate aspects of the acute phase response. Grehan S, Uhlar CM, Sim RB, Herbert J, Whitehead AS. J Immunol; 1997 Jul 01; 159(1):369-78. PubMed ID: 9200475 [Abstract] [Full Text] [Related]
16. Use of genetically altered mice to study the role of serum amyloid P component in amyloid deposition. Maeda S. Amyloid; 2003 Aug 01; 10 Suppl 1():17-20. PubMed ID: 14640037 [Abstract] [Full Text] [Related]
17. Brefeldin A inhibits experimentally induced AA amyloidosis. Stenstad T, Husby G. J Rheumatol; 1996 Jan 01; 23(1):93-100. PubMed ID: 8838515 [Abstract] [Full Text] [Related]
18. Deposition, Clearance, and Reinduction of Amyloid A Amyloid in Interleukin 1 Receptor Antagonist Knockout Mice. Watanabe K, Uchida K, Chambers JK, Ushio N, Nakayama H. Vet Pathol; 2017 Jan 01; 54(1):99-110. PubMed ID: 27565681 [Abstract] [Full Text] [Related]
19. In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis. Li JP, Galvis ML, Gong F, Zhang X, Zcharia E, Metzger S, Vlodavsky I, Kisilevsky R, Lindahl U. Proc Natl Acad Sci U S A; 2005 May 03; 102(18):6473-7. PubMed ID: 15843464 [Abstract] [Full Text] [Related]
20. Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils? Baltz ML, Rowe IF, Caspi D, Turnell WG, Pepys MB. Clin Exp Immunol; 1986 Dec 03; 66(3):701-8. PubMed ID: 3105937 [Abstract] [Full Text] [Related] Page: [Next] [New Search]